Nanospectra Biosciences
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Nanospectra Biosciences sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Nanospectra Biosciences: 3 sponsored US clinical trials, none currently recruiting.
Nanospectra Biosciences sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. The most-studied condition in this pipeline is Neoplasms of the Prostate, with 1 trials.
Upper-quartile sponsor footprint
Nanospectra Biosciences sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
NCT02680535
Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
NCT01679470
Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck
NCT00848042
Therapeutic Areas
How the Nanospectra Biosciences archive is shaped
3 indexed studies, none listed as recruiting (0% open); 2 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Neoplasms of the Prostate (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Nanospectra Biosciences: archived-pipeline peers nationwide
Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Nanospectra Biosciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 archived trials
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
- 3EO Health · 0% recruiting · 2 trials
Related
What to do with this Nanospectra Biosciences page
3 registered trials is a research-attention snapshot, not an endorsement of Nanospectra Biosciences or any single study.
- None of Nanospectra Biosciences's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Neoplasms of the Prostate is the condition Nanospectra Biosciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Neoplasms of the Prostate trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Nanospectra Biosciences pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.